发明名称 ORAL DOSAGE FORM FOR CONTROLLED DRUG RELEASE.
摘要 <p>An oral dosage form comprising, (i) an erodable core, which core comprises a pharmaceutically active weak base or a pharmaceutically acceptable salt or solvate thereof; and (ii) an erodable coating surrounding said core, which coating comprises one or more openings extending substantially completely through said coating but not penetrating said core and communicating from the environment of use to said core; characterised in that release of the pharmaceutically active weak base or a pharmaceutically acceptable salt or solvate thereof from the dosage form occurs through the said opening(s) by the erosion of said erodable core and through erosion of said erodable coating under pre-determined pH conditions; a process for preparing such a dosage form and the use of such a dosage form in medicine.</p>
申请公布号 MXPA04007794(A) 申请公布日期 2004.10.15
申请号 MX2004PA07794 申请日期 2003.02.12
申请人 GLAXO GROUP LIMITED 发明人 WILLY, HELEN ANNE
分类号 A61K9/30;A61K9/20;A61K31/4439;A61K31/52;A61K47/26;A61K47/32;A61K47/34;A61K47/38;A61K47/46;A61P3/06;A61P3/10;A61P31/22;(IPC1-7):A61K9/44 主分类号 A61K9/30
代理机构 代理人
主权项
地址